Jacobs Levy Equity Management
CORT icon

Jacobs Levy Equity Management’s Corcept Therapeutics CORT Stock Holding History

Jacobs Levy Equity Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.5M Buy
+695,532
New +$42M 0.22% 110
2025
Q4 		– Sell
-3,828
Closed -$318K – 947
2025
Q3 		$318K Sell
3,828
-451,623
-99% -$32.7M ﹤0.01% 874
2025
Q2 		$33.4M Sell
455,451
-894,231
-66% -$64.8M 0.13% 160
2025
Q1 		$154M Sell
1,349,682
-27,199
-2% -$1.66M 0.61% 31
2024
Q4 		$69.4M Buy
1,376,881
+153,100
+13% +$8.02M 0.25% 100
2024
Q3 		$56.6M Buy
1,223,781
+352,947
+41% +$12.5M 0.22% 116
2024
Q2 		$28.3M Buy
870,834
+139,366
+19% +$3.82M 0.12% 180
2024
Q1 		$18.4M Buy
+731,468
New +$17.3M 0.08% 217
2020
Q4 		– Sell
-704,024
Closed -$12.3M – 1027
2020
Q3 		$12.3M Sell
704,024
-165,376
-19% -$2.64M 0.13% 179
2020
Q2 		$14.6M Buy
869,400
+371,270
+75% +$5.22M 0.16% 156
2020
Q1 		$5.92M Buy
+498,130
New +$6.16M 0.08% 264
2018
Q1 		– Sell
-49,310
Closed -$891K – 1008
2017
Q4 		$891K Buy
49,310
+29,500
+149% +$534K 0.02% 637
2017
Q3 		$382K Buy
+19,810
New +$295K 0.01% 746
2015
Q4 		– Sell
-16,200
Closed -$61K – 822
2015
Q3 		$61K Buy
+16,200
New +$82.2K ﹤0.01% 783

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jacobs Levy Equity Management's CORT Position: Q2 2026 in Review

Jacobs Levy Equity Management opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 695,532 shares worth $60.5M. The stake represents 0.22% of the portfolio and ranks #110 among its holdings. This is a return to the name: Jacobs Levy Equity Management previously reported a position in CORT as recently as Q3 2025.

Jacobs Levy Equity Management first reported a position in CORT in Q3 2015 and has held it in 14 quarters since. The position peaked at $154M in Q1 2025. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Jacobs Levy Equity Management held 695,532 shares of Corcept Therapeutics worth $60.5M as of Q2 2026.
  • Corcept Therapeutics was a new Jacobs Levy Equity Management position in Q2 2026.
  • Corcept Therapeutics made up 0.22% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #110 holding.
  • Jacobs Levy Equity Management first reported a position in Corcept Therapeutics in Q3 2015 and has held it in 14 quarters since.
  • Jacobs Levy Equity Management's Corcept Therapeutics position peaked at $154M in Q1 2025.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.